Australia Clinical (Diagnostic and Pathology) Services Market Outlook to 2023

By Radiology Tests (Ultrasound, CT Scan, Diagnostic Radiology, MRI, Nuclear Medicine Imaging and Others) and Pathology Tests (Chemical, Microbiology, Tissue Pathology, Haematology, Patient Episode Initiation, Immunology and Others)

Region:Asia

Author(s):

Product Code:KR739

Download Sample Report download
Buy the Full ReportStarting from $3750
Published on

December 2018

Total pages

108

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3750

About the Report

About the Report

The report titled "Australia Clinical (Diagnostic and Pathology) Services Market Outlook to 2023 - By Radiology Tests (Ultrasound, CT Scan, Diagnostic Radiology, MRI, Nuclear Medicine Imaging and Others) and Pathology Tests (Chemical, Microbiology, Tissue Pathology, Haematology, Patient Episode Initiation, Immunology, and Others)" provides a comprehensive analysis of diagnostic imaging and pathology services industry in Australia. The report focuses on overall market size for diagnostic and pathology services in different states across Australia, market segmentation by requesting provider (GP, Specialist, Allied Health and Dentist), by type of test (Radiology Tests (Ultrasound, CT Scan, Diagnostic Radiology, MRI, Nuclear Medicine Imaging and Others) and Pathology Tests (Chemical, Microbiology, Tissue Pathology, Hematology, Patient Episode Initiation, Immunology, and Others)) and by state (NSW, VIC, QLD, WA, SA, TAS, ACT and NT). The report also covers Australia's diagnostic imaging equipment market size and segmentation by equipment and a Snapshot on the POCT market in Australia.
The report also provides a holistic view of the overall clinical market (diagnostic & pathology) ecosystem, value chain analysis, mediclaim process, and medicare programme, growth drivers, restraints along with market share of leading clinical labs (I-MED Radiology, Sonic Healthcare, Primary Health Care, Integral Diagnostic, Capitol Health Limited, Qscan Radiology Clinics, PRP Diagnostic Imaging, Benson Radiology, Australian Clinical Labs, SA Pathology & Other Players).
The report also includes SWOT analysis, entry barriers, regulations for pathology laboratories, collection centers, packaging and quality control of specimens. The report also includes future projections for diagnostic imaging and pathology services market size and future projections by type of test in the diagnostic and pathology services market. The report concludes with analyst recommendations highlighting the major opportunities and cautions
Australia Clinical (Diagnostic Imaging & Pathology) Services Market
Diagnostic Imaging Market Size
In terms of revenue, the Australian diagnostic imaging market has registered a constant growth with positive CAGR in the last five years (FY'2012- FY'2018E). The diagnostic imaging market has witnessed an overall rise in bulk-billing rates in 2017. Key initiatives in the last 5 years included increasing the number of MBS-eligible MRI machines and improved “appropriate requesting” by health professionals to promote more efficient and effective use of diagnostic imaging services. There has been an overall improvement in patient access to MRI services but the “appropriate requesting” initiative was not substantively implemented.
Pathology Services Market Size
The pathology services market has also grown at a steady pace in the past few years. The pathology market in Australia is in its late growth stage. Australia is known to provide the best value for money in pathology while maintaining high service quality, even better than the US, Canada or Japan. The pathology sector has the highest bulk-billing rate of any medical service in Australia.
Australia Diagnostic Imaging and Pathology Services Market Segmentation
Segmentation by Type of Tests
Diagnostic Imaging Market: The highest contribution in revenues in the diagnostic imaging market is from ultrasound, followed by CT scan and diagnostic radiology tests. The least revenue contribution is from nuclear medicine imaging as cases in which these tests are ordered are very less. On the other hand revenue from MRI scans has grown at an overwhelming pace in the last five years.
Pathology Services Market: The highest revenue contribution in the pathology services market is from the chemical tests followed by microbiology and tissue pathology with the second and third highest revenue contribution. The immunology test had the least contribution to the overall revenues of the pathology services market in Australia.
Segmentation by Requesting Providers
Diagnostic Imaging Market: The highest contribution in revenues is from general practitioners (GP), followed by specialists, dentists, and allied health providers. The number of GP's has been rising in the country in the past few years.
Pathology Services Market: In the pathology service market, the majority of the revenue contribution is by the general practitioners followed by specialists. The contribution by dentists and allied health service providers is very minimal. A rise in the number of pathology services was driven by the growing prevalence of chronic diseases and incline in the number of GPs.
Segmentation by State
Diagnostic Imaging Market: State-wise, the revenue share of New South Wales (NSW) has been the largest followed by Victoria (VIC) and Queensland (QLD). The least revenue share was from the Northern Territory (NT).
Pathology Services Market: In the pathology services market as well New South Wales dominated the market followed by Victoria (VIC) and Queensland (QLD). The highest demand for pathology tests is from NSW while the least demand is from the Northern Territory (NT).
Competition
Diagnostic Imaging Market: Australia's diagnostic imaging market is a fragmented space. Several private equity firms have ventured into space and consolidation is well underway, with more mergers and acquisitions expected in the near future.
Pathology Services Market: Australia pathology services market is a consolidated space with a supermarket-style duopoly were the top 2 players comprised for a majority of the share of the market in FY'2018. In 2010, the government removed restrictions on the number of collection centers a pathology network could operate, resulting in intense competition for collection centers. Since deregulation, the number of centers has more than doubled.
Future Projections
Diagnostic Imaging Market: The diagnostic imaging market is likely to grow at a positive CAGR during 2019-2023. The market will be driven by ageing population, the addition of services to Medicare rebates such as cardiac and prostate MRI. The announcement of indexations in schedule fees by Medicare will also potentially aid in the market growth in the near future.
Pathology Services Market: The revenue growth in pathology services is expected to be positive in the coming years. The market will be driven by reversal to cuts in Bulk Bill incentives, implementation of national screening programs and rising trend of outsourcing by public hospitals to private service providers.
Key Segments Covered
By Type of Tests
Diagnostic Imaging
Ultrasound
CT Scan
Diagnostic Radiology
MRI
Nuclear Medicine Imaging and Others
Pathology Services
Chemical
Microbiology
Tissue Pathology
Hematology
Patient Episode Initiation
Immunology and Others
By Requesting Provider
GP
Specialist
Allied Health
Dentist
By State
New South Wales (NSW)
Victoria (VIC)
Queensland (QLD)
Western Australia (WA)
South Australia (SA)
Tasmania (TAS)
Australian Capital Territory (ACT)
Northern Territory (NT)
Key Target Audience
Diagnostic Imaging Service Provider Companies
Pathology Service Provider Companies
Private Hospitals
Diagnostic Imaging and Pathology services equipment and consumables providers
Private Equity Ventures
Time Period Captured in the Report
2012-2018 - Historical Period
2019-2023 - Future Forecast
Companies Covered
Diagnostic Imaging and Pathology Services Companies
I-MED Radiology
Sonic Healthcare
Primary Health Care
Integral Diagnostic
Capitol Health Limited
Qscan Radiology Clinics
PRP Diagnostic Imaging
Benson Radiology
Australian Clinical Labs
SA Pathology
Key Topics Covered in the Report
Overview of Australia Clinical (Diagnostic and Pathology) Services Market
Value Chain Analysis in Australia Clinical (Diagnostic and Pathology) Services Market
Mediclaim Process
Overview of the Medicare Program
Australia Diagnostic Imaging and Pathology Services Market - Growth Drivers
Australia Diagnostic Imaging and Pathology Services Market - Restraints
Australia Diagnostic Imaging Market Size- by Revenue & and Number of Patients
Australia Pathology Services Market Size- by Revenue & and Number of Patients
Australia Diagnostic Imaging Market Segmentation- by Type of Tests
Australia Diagnostic Imaging Market Segmentation- by Requesting Provider
Australia Diagnostic Imaging Market Segmentation- by State
Australia Pathology Services Market Segmentation- by Type of Tests
Australia Pathology Services Market Segmentation- by Requesting Provider
Australia Pathology Services Market Segmentation- by State
Australia Diagnostic Imaging Market Share
Australia Pathology Services Market Share
SWOT Analysis
Regulations in Pathology Service Market
Australia Diagnostic Imaging Market Analyst Recommendations
Australia Pathology Services Market Analyst Recommendations

Products

Products

Diagnostic Imaging (Ultrasound, CT Scan, Diagnostic Radiology, MRI and Nuclear Medicine Imaging and Others)

Pathology Services (Chemical, Microbiology, Tissue Pathology, Heamtology, Patient Episode Initiation and Immunology and Others)

By Requesting Provider (GP, Specialist, Allied Health and Dentist)

By State (New South Wales (NSW), Victoria (VIC), Queensland (QLD), Western Australia (WA), South Australia (SA), Tasmania (TAS), Australian Capital Territory (ACT) and Northern Territory (NT))


Companies

I-MED Radiology

Sonic Healthcare

Primary Health Care

Integral Diagnostic

Capitol Health Limited

Qscan Radiology Clinics

PRP Diagnostic Imaging

Benson Radiology

Australian Clinical Labs

SA Pathology

Table of Contents

Table of Contents

1. Australia Clinical Laboratory Market (Diagnostic Imaging and Pathology Services)- Executive Summary

2. Australia Diagnostic Imaging Market- Executive Summary

3. Research Methodology

3.1. Market Definitions

3.2. Abbreviations

3.3. Consolidated Research Approach

3.4. Market Sizing and Limitations

3.5. Variables (Dependent and Independent)

3.6. Australia Clinical Lab Market Correlation Matrix

3.7. Australia Clinical Lab Market Regression Matrix

4. Australia Diagnostic Imaging and Pathology Services Market Ecosystem

5. Australia Diagnostic Imaging and Pathology Services Market - Value Chain Analysis

6. Australia Diagnostic Imaging and Pathology Services Market - Mediclaim Process

7. Australia Diagnostic Imaging and Pathology Services Market - Medicare Program

8. Australia Diagnostic Imaging and Pathology Services Market - Growth Drivers

9. Australia Diagnostic Imaging and Pathology Services Market - Restraints

10. Australia Diagnostic Imaging Market

10.1. Market Size - By Revenue, FY'2012-FY'2018E and Number of Tests, FY'2012-FY'2017E

10.1.1 Australia Diagnostic Imaging Market Timeline of Companies with Number of Clinics & Growth in Type of Test

10.2. Market Segmentation by Requesting Provider, FY'2012-FY'2017

10.2.1. Australia Diagnostic Imaging Market -General Practitioner (GP) Head Count Segmentation by State, FY'2012-FY'2017

10.2.2. Australia Diagnostic Imaging Market -General Practitioner (GP) Head Count Segmentation by State, FY'2012-FY'2017

10.2.3. Australia Diagnostic Imaging Market No. of Medical practitioners registration type by state or territory, August 2018

10.2.4. Australia Diagnostic Imaging Market No of Medical Practitioners Registered by State and by Field of Specialty, August 2018

10.2.5. Australia Diagnostic Imaging Market No of Public & Private Hospitals by State, FY'2012-FY'2017

10.3. Market Segmentation by Type of Test, FY'2012-FY'2017

10.3.1. Market Segmentation by Type of Test (Ultrasound), FY'2012-FY'2017

10.3.2. Market Segmentation by Type of Test (CT Scan), FY'2012-FY'2017

10.3.3 .Market Segmentation by Type of Test (Diagnostic Radiology), FY'2012-FY'2017

10.3.4. Market Segmentation by Type of Test (MRI), FY'2012-FY'2017

10.3.5. Market Segmentation by Type of Test (Nuclear Medicine), FY'2012-FY'2017

10.3.6. Comparative Analysis for Radiology Tests In Australia

10.4. Market Segmentation by State, FY'2012-FY'2017

11. Australia Diagnostic Imaging Market Competitive Scenario

11.1. Australia Diagnostic Imaging Market Competitive Scenario- Market Share

11.2. Australia Diagnostic Imaging Market Competitive Scenario- Company Profile

11.2.1. Company Profile- I-MED Radiology

11.2.2. Company Profile- Sonic Healthcare

11.2.3. Company Profile- Primary Health Care

11.2.4. Company Profile- Integral Diagnostics

11.2.5. Company Profile- Capitol Health Limited

11.2.6. Company Profile- Qscan Radiology Clinics

11.2.7. Company Profile- PRP Diagnostic Imaging

11.2.8. Company Profile- Benson Radiology

11.2.9. Company Profile- Other Major Players (Canberra Imaging Group and ALFRED Imaging)

11.2.10. Comparative Analysis of Companies in Australia Diagnostic Imaging Market

12. Australia Diagnostic Imaging Services Market - Investment Model

13. Australia Diagnostic Imaging Equipment Market Scenario

14. Australia Diagnostic Imaging Market Future Outlook and Projections

14.1. Market Size Future Outlook and Projections, FY'2019E-FY'2023E

14.2. Market Segmentation Future Outlook and Projections- By Type of Test, FY'2022E

15. Australia Diagnostic Imaging Market - Analyst Recommendations

16. Snapshot on POCT Market Australia

17. Australia Pathology Services Market - Executive Summary

18. Australia Pathology Services Market

18.1. Market Size - By Revenue, FY'2012-FY'2018E and Number of Tests, FY ‘2012-FY'2017E

18.1.1. Timeline of Companies With Number of Clinics & Growth in Type of Test

18.2. Market Segmentation by Requesting Provider, FY'2012-FY'2017

18.2.1. Australia Pathology Service Market Type of Tests Referred and Incentive Mechanism by Requesting Provider

18.3. Market Segmentation by Type of Test, FY'2012-FY'2017

18.4. Market - Segmentation by State, FY'2012-FY'2017

19. Australia Pathology Services Market Regulations

19.1. Regulations for Pathology Laboratories and Collection Centers

19.2. Regulations for Packaging and Quality Control of Specimens

20. Australia Pathology Services Market Competition Scenario

20.1. Australia Pathology Services Market Competition Scenario- Market Share

20.2. Australia Pathology Services Market Competition Scenario- Company Profiles

20.2.1. Company Profile- Australian Clinical Labs (formerly Healthscope)

20.2.2. Company Profile- SA Pathology

20.3. Comparative Analysis of Companies in Australia Pathology Services Market

21. Australia Pathology Services Market - SWOT Analysis

22. Entry Barriers in Australia Pathology and Diagnostic Imaging Market

23. Australia Pathology Services Market Future Outlook and Projections

23.1. Market Size Future Outlook and Projections, FY'2019E-FY'2023E

23.2. Market Segmentation Future Outlook and Projections - By Type of Test, FY'2022

24. Australia Pathology Services Market - Analyst Recommendations

Contact Us

Disclaimer


List of Figure

Figure 1.1: Australia Clinical Laboratory Market Size by Revenue, FY'2012, FY'2018E and FY'2023E

Figure 1.2: Australia Clinical Laboratory Market Segmentation by Diagnostic & Pathology FY'2017- FY'2022E

Figure 2.1: Australia Diagnostic Imaging Market Size by Revenue, FY'2012, FY'2018E and FY'2023E

Figure 2.2: Australia Diagnostic Imaging Market Segmentation by Type of Service, FY'2017 & FY'2022

Figure 8.1: Australia No. of Births in Thousand, 2011-2017E

Figure 8.2: Australia No. of Diagnostic Tests Per Person, FY'2012-FY'2017E

Figure 10.1: Australia Diagnostic Imaging Market Size by Revenue in AUD Million, FY'2012-FY'2018E

Figure 10.2: Rise in Number of Medicare Funded Radiology Tests, FY'2012-FY'2017E

Figure 10.3: Rise in Number of Medicare Funded Different Diagnostic Tests, FY'12-FY'16

Figure 10.4: Australia Diagnostic Imaging Market Overall Revenue by Requesting Provider in AUD Million, FY'2012-FY'2017

Figure 10.5: Australia GP Head Count Segmentation by State in Thousand, FY'2012-FY'2017

Figure 10.6: Australia GP Head Count per Population Segmentation by State, FY'2012-FY'2017

Figure 10.7: Australia No of Medical Practitioners Registered by State in Percentage (%), August 2018

Figure 10.8: Australia Diagnostic Imaging Market Segmentation by Type of Test on the Basis of Revenue in Percentage (%), FY'2012-FY'2017

Figure 10.9: Australia Diagnostic Imaging Market Share of Ultrasound on the Basis of Revenue in Percentage (%), FY'2017

Figure 10.10: Australia Diagnostic Imaging Market Share of CT Scan on the Basis of Revenue in Percentage (%), FY'2017

Figure 10.11: Australia Diagnostic Imaging Market Share of Diagnostic Radiology on the Basis of Revenue in Percentage (%), FY'2017

Figure 10.12: Australia Diagnostic Imaging Market Share of MRI on the Basis of Revenue in Percentage (%), FY'2017

Figure 10.13: Australia Diagnostic Imaging Market Share of Nuclear Medicine on the Basis of Revenue in Percentage (%), FY'2017

Figure 10.14: Australia Diagnostic Imaging Market by State on the Basis of Revenue in Percentage (%), FY'2012 and FY'2017

Figure 11.1: I-Med Radiology Revenue from in AUD Million, FY'2014-FY'2016

Figure 11.2: Sonic Healthcare Revenue from Pathology Services in Australia in AUD Million, FY'2012-FY'2018

Figure 11.3: Sonic Healthcare Revenue from Diagnostic Imaging Services in Australia in AUD Million, FY'2012-FY'2018

Figure 11.4: Primary Healthcare (Healthcare Imaging Services) Revenue & EBITDA in AUD Million, FY'2012-FY'2017

Figure 11.5: Primary Healthcare Pathology Segment Revenue & EBITDA in AUD Million, FY'2012-FY'2017

Figure 11.6: Integral Diagnostics Revenue and EBITDA in AUD Million, FY'2013-FY'2017

Figure 11.7: Capitol Health Limited Revenue in AUD Million, FY'2013-FY'2018

Figure 11.8: Capitol Health Limited EBITDA in AUD Million, FY'2015-FY'2018

Figure 13.1: Australia Diagnostic Imaging Equipment Market Revenue in AUD Million, FY'2013-FY'2017

Figure 13.2: Australia Diagnostic Imaging Equipment Market Revenue by Equipments in Percentage (%), FY'2017

Figure 14.1: Australia Diagnostic Imaging Market Revenue in AUD Million, FY'2019E-FY'2023E

Figure 14.2: Australia Diagnostic Imaging Market Revenue by Type of Test on the Basis of Revenue in Percentages (%), FY'2022E

Figure16.1: Australia POCT Market Size on the Basis of Revenue in USD Million, 2014-2020E

Figure 16.2: Australia POCT Market Segmentation by Type of POC Test on the Basis of Revenue in Percentage, 2017

Figure 17.1: Australia Pathology Services Market Size by Revenues in AUD Million, FY'2012, FY'2018E and FY'2023E

Figure 17.2: Australia Pathology Services Market Segmentation, FY'2017-FY'2022

Figure 18.1: Australia Pathology Services Market Revenue in AUD Million, FY'2012-FY'2018E

Figure 18.2: Rise in Number of Medicare Funded Pathology Tests, FY'2012-FY'2017E

Figure 18.3: Rise in Number of Medicare Funded Different Pathology Tests, FY'2012-FY2017

Figure 18.4: Australia Pathology Services Market by Type of Test on the Basis of Revenue in Percentage (%), FY'2012 and FY'2017

Figure 18.5: Australia Pathology Services Market by State on the Basis of Revenue in Percentage (%), FY'2012 and FY'2017

Figure 23.1: Australia Pathology Services Market Revenue in AUD Million, FY'2019E-FY'2023E

Figure 23.2: Australia Pathology Services Market by Type of Test on the Basis of Revenue in Percentage (%), FY'2022


List of Table

Table 1.1: Australia Clinical Laboratory Market (Diagnostic Imaging & Pathology Market Major Service Providers, Average Revenue per Annum & Major Investors)

Table 2.1: Australia Diagnostic Imaging Market (Major Service Providers, No. of Diagnostic Clinics, Average Revenue & Major Investors)

Table 3.1: Correlation Matrix for Australia Clinical Lab Market

Table 3.2: Regression Coefficient Output for Australia Clinical Lab Market

Table 8.1: Incidence of Major Cancers in Australia

Table 9.1: List of Tests not Covered by Medicare

Table 9.2: List of Tests with Specific Medicare Requirements

Table 10.1: Australia Diagnostic Imaging Market Timeline of Companies with No. of Centres

Table 10.2: Number of Medicare Services (Test) by Requesting Providers in Million, FY'2012-FY'2017E

Table 10.3: Number of Medicare Patients by Requesting Providers in Million, FY'2012-FY'2017E

Table 10.4: Australia Diagnostic Imaging Market Type of Tests Referred and Incentive Mechanism by Requesting Providers

Table 10.5: Australia GP Head Count Segmentation by State, FY'2012-FY'2017

Table 10.6: Australia GP Head Count per 100,000 Population Segmentation by State, FY'2012-FY'2017

Table 10.7: Australia No of Medical Practitioners Registered by Field of Specialty, August 2018

Table 10.8: Australia No of Medical Practitioners Registered by Field of Specialty, August 2018

Table 10.9: Australia No of Private Hospitals by State, FY'2012-FY'2016

Table 10.10: Australia No of Public Hospitals by State, FY'2013-FY'2017

Table 10.11: Australia Diagnostic Imaging Market Segmentation by Type of Test on the Basis of Revenue in AUD Million, FY'2012-FY'2017

Table 10.12: Australia Ultrasound Market by Number of Tests, Number of Patients, FY'2012 and FY'2017

Table 10.13: Australia CT Scan Market by Number of Tests, Number of Patients, FY'2012 and FY'2017

Table 10.14: Australia Diagnostic Radiology Market by Number of Tests, Number of Patients, FY'2012 and FY'2017

Table 10.15: Australia MRI Market by Number of Tests, Number of Patients, FY'2012 and FY'2017

Table 10.16: Australia Nuclear Medicine Market by Number of Tests, Number of Patients, FY'2012 and FY'2017

Table 10.17: Comparison of Radiology Tests in Australia on the Basis of Cost for Test, Specialized Chains and New Technology

Table 10.18: Australia Diagnostic Imaging Market by State in AUD Million, FY'2012-FY'2017

Table 10.19: Number of Medicare Funded Services (Test) by State in Million, FY'2012-FY'2017

Table 10.20: Number of Medicare Funded Patients by State in Million, FY'2012-FY'2017

Table 10.21: Population Penetration for Number of Medicare Funded Tests, FY'2016-FY'2017

Table 10.22: Number of Hospitals by Regions in Australia, FY'2016-FY'2017

Table 10.23: Population Penetration for Number of Medicare Funded Patients, FY'2016-FY'2017

Table 10.24: Number of Hospital Beds by Regions in Australia, FY'2016-FY'2017

Table 10.25: Australia Diagnostic Imaging Market Major Causes of Death Segmentation by State, FY'2016

Table 11.1: Australia Diagnostic Imaging Market Share on the Basis Revenue in Percentage (%) and Number of Clinics, FY'2017

Table11.2: Australia Diagnostic Imaging Services Market Competitive Scenario

Table 11.3: I-MED Radiology Profile including Company Overview, Number of Clinics, Business Strategies and other KPIs

Table 11.4: I-MED Radiology Profile including Diagnostic Equipments, Business Strategies and Major Regions

Table 11.5: Sonic Healthcare Profile including Company Overview, Collection Centres, No of Employees and Business Segments

Table 11.6: Sonic Healthcare Profile including Business Strategies, Mergers and Acquisitions, Brands and Subsidiaries

Table 11.7: Primary Healthcare Company Profile including Company Overview, No of Clinics, No of Employees & Region wise locations

Table 11.8: Primary Healthcare Company Profile including Services offered, Business strategies, Pathology Services Business

Table 11.9: Integral Diagnostics Profile including Company Overview, Region Wise Sites and No of Employees

Table 11.10: Integral Diagnostics Profile including Business Strategies, Subsidiaries, Equipments and Acquisitions

Table 11.11: Capitol Health Limited Profile including Company Overview, Radiology Clinics, Business Strategies, Acquisitions and Major regions

Table 11.12: Capitol Health Limited Profile including Associated Brands, Number of Employees and Services

Table 11.13: Qscan Radiology Clinics Profile including Company Overview, Radiology Clinics, No of Employees, Business Strategy, M&A's and Services

Table 11.14: Company Profiles of PRP Diagnostic Imaging Including Company Overview, No of Radiology Clinics, Revenue, Strength, Weakness, Services, Major Regions and Mergers and Acquisitions

Table 11.15 Company Profiles Benson Radiology Including, Company Overview, No of Clinics, Major Regions, No. of Employees, Revenue, Strength, Weakness, Services and Equipment and Infrastructure

Table 11.16: Company Profiles of Other Major Players Including Canberra Imaging Group and ALFRED Imaging

Table 11.17 Comparative Analysis of Companies in Australia Diagnostic Imaging Market

Table 12.1: Assumptions Undertaken for the Investment Model

Table 12.2: Investment Model Average Revenue of tests and Assumptions for Average Number of Tests per day

Table 12.3: Average Price of Diagnostic Imaging Tests

Table 12.4: Human Resource Requirements for Diagnostic Imaging Centre

Table 12.5: Capital Cost of Diagnostic Equipments

Table 12.6: Fixed Cost Required

Table 12.7: Operating Revenue Analysis

Table 12.8: Operating Cost Required

Table 12.9: Profitability Analysis

Table 13.1: Australia Diagnostic Imaging Equipment Market Effective Life, Maximum Life, Major Companies and Prices

Table 14.1: Australia Diagnostic Imaging Market by Type of Test Revenue in AUD Million, FY'2017, FY'2022E & CAGR

Table 16.1: Snapshot on POCT Market Australia

Table 17.1: Australia Pathology Services Market Major Service Providers, Pathology Labs, Collection Centres, Average Revenue, Specimen Collection, Laboratory Practice

Table 18.1: Australia Pathology Services Market Timeline of Companies with No of Centres

Table 18.2: Australia Pathology Services Market by Requesting Provider on the Basis of Revenue in AUD Million, FY'2012-FY'2017

Table 18.3: Number of Medicare Services by Requesting Providers in Million, FY'2012-FY'2017E

Table 18.4: Number of Medicare Patients by Requesting Providers in Million, FY'2012-FY'2017E

Table 18.5: Australia Pathology Services Market Type of Tests Referred and Incentive Mechanism by Requesting Providers

Table 18.6: Australia Pathology Services Market by Type of Test in AUD Million, FY'2012-FY'2017

Table 18.7: Australia Pathology Services Market Most Commonly Requested Test in Each Category

Table 18.8: Australia Pathology Services Market Segmentation by Type of Test, FY'2012-FY'2017

Table 18.9: Number of Medicare Funded Services by Type of Test in Million, FY'2012-FY'2017

Table 18.10: Number of Medicare Funded Patients by Type of Test in Million, FY'2012-FY'2017

Table 18.11: Australia Pathology Services Market by State in AUD Million, FY'2012-FY'2017

Table 18.12: Number of Medicare Funded Services by State in Million, FY'2012-FY'2017

Table 18.13: Number of Medicare Funded Patients by State in Million, FY'2012-FY'2017

Table 18.14: Number of Medicare Funded Patients by State in Million, FY'2012-FY'2017

Table 20.1: Australia Pathology Services Market Share on the Basis Revenue, Revenue Share and Labs, FY'2017

Table 20.2: Australia Pathology Services Market Scenario

Table 20.3: Australian Clinical Labs Profile including Company Overview, Laboratories & Collection Centres, No of Employees, Annual Revenue, Business Strategies

Table 20.4: SA Pathology Profile including Company Overview, Laboratories and Collection Centres, No of Employees, Annual Revenues, Business Strategies

Table 20.5: Comparative Analysis of Companies in Australia Pathology Services Market

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022